FDA's Shocking Approval: Rexulti Fast-Tracked Despite Deadly Risks
Por um escritor misterioso
Descrição
Investigation raises serious questions about the harm-benefit balance of Rexulti; the Decision may reverse efforts to reduce the use of antipsychotics in US care homes. During testing, the antipsychotic medication brexpiprazole (Rexulti) did not demonstrate a significant therapeutic effect and was
Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for
FDA's Fast-Track for Rexulti Raises Concerns
FDA fast-tracking approval of new drugs — fewer trials, less info
Otsuka and Lundbeck Issue Statement on U.S. Food and Drug
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's
Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for
FDA Approves Rexulti for Agitation Associated With Dementia Due to
FDA rushes approval of dementia drug that quadruples risk of death
FDA rules Otsuka marketing claim overstates Rexulti efficacy
FDA fast-tracking approval of new drugs — fewer trials, less info
FDA's Shocking Approval: Rexulti Fast-Tracked Despite Deadly Risks
de
por adulto (o preço varia de acordo com o tamanho do grupo)
